Skip to main content
. 2021 Mar 26;47(3):101254. doi: 10.1016/j.diabet.2021.101254

Table 3.

Association of hyperglycaemia and diabetes with the time to death using stepwise Cox regression (n = 373).

Covariates HR 95% CI
Step 1: using 59 covariatesa
Fatigue 3.33 1.53–7.23
Dialysis 2.95 1.21–7.22
Differential neutrophil countb 1.05 1.01–1.08
Initial Serum globulin (g/L) 2.25 1.32–3.84
Initial Platelet count (x109 cells/L) 0.99 0.99–1.00
Steroids 12.21 1.49–100.0
Step 2: Step 1 covariates + hyperglycaemia
Hyperglycaemia 5.56 1.62–19.0
Fatigue 3.24 1.46–7.16
Age (y) 1.03 1.01–1.06
Steroids 13.88 1.64–117.65
Initial Serum globulin (g/L) 2.15 1.31–3.50
Initial platelet count (x109 cells/L) 0.99 0.99–1.00
Differential neutrophil countb(%) 1.04 1.00–1.08
Marijuana use 6.07 1.24–29.6
Rivaroxaban 8.37 1.04–66.8
Step 3: Step 1 covariates + combination of diabetes and hyperglycaemia
Glycaemic status
 No-diabetes/no-hyperglycaemia Ref
 No-diabetes/hyperglycaemia 8.86 1.90–41.4
 Diabetes/no-hyperglycaemia 10.6 0.85–131.8
 Diabetes/hyperglycaemia 7.58 1.73–33.1
Fatigue 3.41 1.49–7.80
Age (y) 1.04 1.01–1.06
Steroids 16.0 1.83–139.8
Initial Serum globulin (g/L) 2.26 1.41–3.60
Initial Platelet count (x109 cells/L) 0.99 0.99–1.00
Differential neutrophil countb(%) 1.04 1.01–1.07
Marijuana use 5.19 0.99–160.5
Rivaroxaban 9.63 1.19–78.3

HR, hazards ratio; CI, confidence interval; Ref, reference category.

Abbreviations: % — percentage, y — years, g/L — grams per Litre, L — Litre.

a

Results are from the final model retained after stepwise forward addition strategy. The full list of included variables in given in the Methods section. Variables in the final model are shown in the order of entry into the model.

b

used as a continuous variable and expressed as percentage.